Drug-labels.com

Naprosyn E 250mg Tablets - Ect: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
250 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Naprosyn E 250mg Tablets - Ect

ABOUT THIS MEDICATION

What the medication is used for:

Your health care provider has prescribed NAPROSYN for you for one or more of the following medical conditions:

  • For the treatment of the signs and symptoms of osteoarthritis,

    rheumatoid arthritis, ankylosing spondylitis, and juvenile rheumatoid arthritis.

  • For the relief of minor aches and pains in muscles, bones and

    joints, mild to moderate pain accompanied by inflammation in sprains and strains and primary dysmenorrhea.

What it does:

NAPROSYN (naproxen), as a nonsteroidal anti-inflammatory drug (NSAID), can reduce the chemicals produced by your body which cause pain and swelling.

NAPROSYN, as a nonsteroidal anti-inflammatory drug (NSAID), does NOT cure your illness or prevent it from getting worse. NAPROSYN can only relieve pain and reduce swelling as long as you continue to take it.

When it should not be used:

DO NOT TAKE NAPROSYN if you have any of the following medical conditions:

  • Heart bypass surgery (planning to have or recently had)
  • Severe, uncontrolled heart failure
  • Bleeding in the brain or other bleeding disorders
  • Current pregnancy (after 28 weeks of pregnancy)

  • Currently breastfeeding (or planning to breastfeed)
  • Allergy to ASA (Acetylsalicylic Acid) or other NSAIDs

    (Nonsteroidal Anti-Inflammatory Drugs)

  • Ulcer (active)
  • Bleeding from the stomach or gut (active)
  • Inflammatory bowel disease (Crohn’s Disease or Ulcerative Colitis)
  • Liver disease (active or severe)
  • Kidney disease (severe or worsening)
  • High potassium in the blood

Patients who took a drug in the same class as NAPROSYN after a type of heart surgery (coronary artery bypass grafting

(CABG)) were more likely to have heart attacks, strokes, blood clots in the leg(s) or lung(s), and infections or other complications than those who did NOT take that drug.

NAPROSYN should NOT be used in patients under 2 years of age since the safety and effectiveness have NOT been established.

What the medicinal ingredient is:

naproxen

What the important non-medicinal ingredients are:

NAPROSYN SR Tablets contain the following non-medicinal ingredients: hydroxypropyl methylcellulose, magnesium stearate, FD&C Yellow No. 6.

NAPROSYN E Tablets contain the following non-medicinal ingredients: povidone K-90, croscarmellose sodium, magnesium stearate, methacrylic acid copolymer Type C, talc, sodium hydroxide, triethyl citrate.

NAPROSYN Suspension contains the following non-medicinal ingredients: methylparaben, fumaric acid, magnesium aluminum silicate, sodium chloride, sorbitol solution 70%, sucrose, flavour, FD&C Yellow No. 6.

What dosage forms it comes in:

NAPROSYN is available as: enteric coated tablets (250 mg, 375 mg and 500 mg); sustained-release tablet (750 mg); suspension (25 mg/ml).

WARNINGS AND PRECAUTIONS

If you have, or previously had, any of the following medical conditions, see your health care provider to discuss treatment options other than NAPROSYN:

  • Heart Attack or Angina
  • Stroke or Mini-stroke
  • Loss of Vision
  • Current Pregnancy (less than 28 weeks)
  • Congestive Heart Failure

Before taking this medication, tell your health care provider if you have any of the following:

  • High blood pressure
  • High cholesterol
  • Diabetes mellitus or on a low sugar diet
  • Atherosclerosis
  • Poor circulation to your extremities
  • Smoker or ex-smoker
  • Kidney disease or urine problems
  • Previous ulcer or bleeding from the stomach or gut

    (small or large intestine)

  • Previous bleeding in the brain
  • Bleeding problems
  • Family history of allergy to NSAIDs, such as

    acetylsalicylic acid (ASA), celecoxib, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, meloxicam, nabumetone, naproxen, oxaprozin, piroxicam, rofecoxib, sulindac, tenoxicam, tiaprofenic acid, tolmetin, or valdecoxib (NOT a complete list)

  • Family history of asthma, nasal polyps, long-term

    swelling of the sinus (chronic sinusitis) or hives

Also, before taking this medication, tell your health care provider if you are planning to get pregnant.

While taking this medication:

  • tell any other doctor, dentist, pharmacist or other health

    care professional that you see, that you are taking this medication, especially if you are planning to have heart surgery;

  • do NOT drink alcoholic beverages while taking this

    medication because you would be more likely to develop stomach problems;

  • fertility may be decreased. The use of NAPROSYN is not

    recommended in women trying to get pregnant. In women who have difficulty conceiving, stopping NAPROSYN should be considered.

INTERACTIONS WITH THIS MEDICATION

Talk to your health care provider and pharmacist if you are taking any other medication (prescription or non-prescription) such as any of the following (NOT a complete list):

  • Acetylsalicylic Acid (ASA) or other NSAIDs

    • e.g. ASA, celecoxib, diclofenac, ibuprofen,

      indomethacin, ketorolac, meloxicam, naproxen

  • Antacids
  • Antidepressants

    • Selective Serotonin Reuptake Inhibitors (SSRIs)

      • e.g. citalopram, fluoxetine, paroxetine,

        sertraline

  • Blood pressure medications

    • ACE (angiotensin converting enzyme) inhibitors

      • e.g. enalapril, lisinopril, perindopril,

        ramipril

    • ARBs (angiotensin II receptor blockers)

      • e.g. candesartan, irbesartan, losartan,

        valsartan

  • Blood thinners

    • e.g. warfarin, ASA, clopidogrel
  • Corticosteroids (including glucocorticoids)

    • e.g. prednisone
  • Cyclosporin
  • Digoxin
  • Diuretics

    • e.g. furosemide, hydrochlorothiazide
  • Lithium
  • Methotrexate

    • Oral contraceptives
    • Oral hypoglycemics (diabetes medications)
    • Tacrolimus

Your health care provider may prescribe low dose ASA (acetylsalicylic acid) as a blood thinner to reduce your risk of having a heart attack or stroke while you are taking NAPROSYN. Take only the amount of ASA prescribed by your health care provider. You are more likely to upset or damage your stomach if you take both NAPROSYN and ASA than if you took NAPROSYN alone.

PROPER USE OF THIS MEDICATION

NAPROSYN is intended for use in patients greater than 2 years of age for the shortest possible duration.

Usual dose: 18 years of age and older:

Medical ConditionStarting Dose

Maximum

Dose (per day)

Osteoarthritis/Rheumatoid Arthritis/Ankylosing Spondylitis500 mg a day in divided doses.1000 mg
Analgesia/Musculoskeletal Injuries

750 mg divided into either two or three

doses/day.

1000 mg
Dysmenorrhea

500 mg followed by one 250 mg tablet every 6-8 hours, as

required.

1250 mg

Usual dose: Juvenile Rheumatoid Arthritis (2-16 years):

The use of NAPROSYN suspension is recommended for juvenile arthritis in children 2 years or older because it allows for more flexible dose administration based on the child’s weight.

The total daily dose is recommended to be given in two divided doses at 12 hour intervals.

Child’s WeightDose
13 kg (29 lbs)2.5 mL (1/2 tsp) twice a day
25 kg (55 lbs)5 mL (1 tsp) twice a day
38 kg (84 lbs)7.5 mL (1 ½ tsp) twice a day

Bottles of NAPROSYN suspension should be shaken gently before use.

Take NAPROSYN only as directed by your health care provider. Do NOT take more of it, do NOT take it more often and do NOT take it for a longer period of time than your health care provider recommended. If possible, you should take the lowest dose of this medication for the shortest time period.

Taking too much NAPROSYN may increase your chances of

unwanted and sometimes dangerous side effects, especially if you are elderly, have other diseases or take other medications.

If you will be using NAPROSYN for more than 7 days, see your health care provider regularly to discuss whether this medicine is working for you and if it is causing you any unwanted effects.

This medication has been prescribed specifically for you. Do NOT give it to anyone else. It may harm them, even if their symptoms seem to be similar to yours.

NAPROSYN is NOT recommended for use in patients under 2 years of age since safety and effectiveness have NOT been established.

NAPROSYN E and NAPROSYN SR have not been studied in subjects under the age of 18.

NAPROSYN tablets should be swallowed with food or milk. NAPROSYN SR and NAPROSYN E tablets should be swallowed whole; do not split, chew, or crush them.

Missed Dose:

It may be a good idea to ask your doctor or pharmacist ahead of time what to do about missed doses. If you forget to take a dose of NAPROSYN take it as soon as possible, then just carry on with the regular times you take your medication. If you remember your missed dose close to the time of your next dose, do not take the missed dose.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

NAPROSYN may cause some side effects, especially when used for a long time or in large doses. When these side effects occur, you may require medical attention. Report all symptoms or side effects to your health care provider.

NAPROSYN may cause you to become drowsy or tired. Be careful about driving or participating in activities that require you to be alert. If you become drowsy, dizzy or light-headed after taking NAPROSYN, do NOT drive or operate machinery.

NAPROSYN may cause you to become more sensitive to sunlight. Any exposure to sunlight or sunlamps may cause sunburn, skin blisters, skin rash, redness, itching or discolouration, or vision changes. If you have a reaction from the sun, check with your health care provider.

Check with your health care provider IMMEDIATELY if you develop chills, fever, muscle aches or pains, or other flu-like symptoms, especially if they occur before or together with a skin

rash. These symptoms may be the first signs of a SERIOUS ALLERGIC REACTION to this medication.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
SymptomSTOP taking NAPROSYN and get emergency medical attention IMMEDIATELYStop taking NAPROSYN and talk to your physician or pharmacist
Bloody or black tarry stools✓
Shortness of breath, wheezing, any trouble breathing or chest tightness✓
Skin rash, hives, swelling or itching✓
Blurred vision, or any visual disturbance✓
Any change in the amount or colour of your urine (red or brown)✓
Any pain or difficulty experienced while urinating✓
Swelling of the feet, lower legs; weight gain✓
Vomiting or persistent indigestion, nausea, stomach pain or diarrhea✓
Yellow discolouration of the skin or eyes, with or without itchy skin✓
Malaise, fatigue, loss of appetite✓
Headaches, stiff neck✓
Mental confusion, depression✓
Dizziness, lightheadedness✓
Hearing problems✓

This is NOT a complete list of side effects. If you develop any other symptoms while taking NAPROSYN, see your health care provider.

HOW TO STORE IT

NAPROSYN SR tablets and NAPROSYN E tablets: Store at room temperature (15-30°C). Store in a dry place.

NAPROSYN Suspension: Store at room temperature not exceeding 25°C, with protection from light. Store upright.

Do NOT keep outdated medicine or medicine no longer needed. Any outdated or unused medicine should be returned to your pharmacist.

Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

--------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701D

      Ottawa, Ontario

      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found at:

www.rochecanada.com

or by contacting the sponsor, Hoffmann-La Roche Limited, at: 1-888-762-4388 (Drug Information).

NAPROSYN is a Registered Trade-Mark of SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED, used under license

Last revised: January 8, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02162792

Revision date stated in the text: January 8, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Naprosyn E 250mg Tablets - Ect

Rx or OTC
Prescription (Rx)?
DIN 02162792
Schedule(s) PRESCRIPTION
Active ingredient(s) Naproxen 250 MG
Dosage form(s) Tablet (Enteric-Coated)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. M Musculo-skeletal system drugs
    1. M01 Antiinflammatory and antirheumatic products
      1. M01A Antiinflammatory and antirheumatic products, non-steroids
        1. M01AE Propionic acid derivatives, antiinflammatory and antirheumatic products
          1. M01AE02 Naproxen
Company HOFFMANN-LA ROCHE LIMITED
Current status Cancelled Post Market
Current status date February 5, 2014

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.